MOCHIDA PHARM. financial statements, including revenue, expenses, profit, and loss

The total revenue of MFY for the last quarter is 184.55 M EUR, and it's 17.89% higher compared to the previous quarter. The net income of Q3 23 is 10.31 M EUR.